AnujBhargavaMD

Endocrinology • West Des Moines, IA

Diabetes, Lipid Metabolism, Thyroid

CEO and Medical Director, Iowa diabetes Research Founder and CEO, My Diabetes Home

Join to view full profile

Dr. Bhargava is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bhargava's full profile

Already have an account?

Office
1031 Office Park Rd
Ste 2
West Des Moines, IA 50265
Phone+1 515-329-6800

Education & Training

University of Wisconsin Hospitals and ClinicsFellowship, Endocrinology, Diabetes, and Metabolism, 1999 - 2002
Wright State UniversityResidency, Internal Medicine, 1996 - 1999
Maulana Azad Medical CollegeClass of 1996

Certifications & Licensure

IA State Medical License 2001 - 2026
WI State Medical License 1999 - 2003
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

Fellow (FACP) American College of Physicians, 2005
Fellow (FACE) American Association of Clinical Endocrinology

Clinical Trials

Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18
Completed
Phase 3
A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM) Start of enrollment: 2014 Feb 01
Terminated
Phase 4
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2014 Apr 01
Terminated
Phase 2
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes Start of enrollment: 2014 Apr 01
Completed
Phase 2
Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients Start of enrollment: 2015 Aug 01
COMPLETED
NA
An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2015 Oct 20
Completed
Phase 3
A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy Start of enrollment: 2016 Dec 01
Completed
Phase 2
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2017 May 24
Completed
Phase 2
A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH) Start of enrollment: 2019 Nov 19
COMPLETED
PHASE2
A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2020 Jul 01
Completed
Phase 2
A Study of LY3209590 in Participants With Type 1 Diabetes Start of enrollment: 2020 Jul 06
Completed
Phase 2
A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin Start of enrollment: 2020 Oct 19
Completed
Phase 3
A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes Start of enrollment: 2020 Oct 30
Completed
Phase 2
A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range) Start of enrollment: 2020 Nov 04
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

2 citations
A Randomized Trial Comparing Inhaled Insulin Plus Basal Insulin Versus Usual Care in Adults With Type 1 Diabetes.
Irl B Hirsch, Roy W Beck, Martin C Marak, Yogish Kudva, Halis K Akturk
Diabetes Care. 2025-03-01
Safety and Effectiveness of MiniMed™ 780G Advanced Hybrid Closed-Loop Insulin Intensification in Adults with Insulin-Requiring Type 2 Diabetes.
Anuj Bhargava, Richard M Bergenstal, Mark L Warren, James R Thrasher, Michael A Dempsey
Diabetes Technology & Therapeutics. 2025-02-06
1 citations
Multicenter Evaluation of Ultra-Rapid Lispro Insulin with Control-IQ Technology in Adults, Adolescents, and Children with Type 1 Diabetes.
Carol J Levy, Ryan Bailey, Lori M Laffel, Gregory Forlenza, Linda A DiMeglio
Diabetes Technology & Therapeutics. 2024-09-01

Journal Articles

Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults with Type 1 Diabetes
Anuj Bhargava, Robin Goland, Irl B Hirsch, Yogish C Kudva, Janet B Mcgill, Louis Philipson, Francesco Vendrame, Ruth S Weinstock, JAMA
Day‐to‐Day Fasting Self‐Monitored Blood Glucose Variability Is Associated with Risk of Hypoglycaemia in Insulin‐Treated Patients with Type 1 and Type 2 Diabetes: A Pos...
Gregg Gerety, Anuj Bhargava, Carol H Wysham, Diabetes, Obesity and Metabolism

Authored Content

Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults with Type 1 DiabetesJune 2020

Press Mentions

Medicap Pharmacy and Iowa Diabetes Form New Partnership to Better Serve Iowa’s Diabetics | HealthMarch 13th, 2023
LILLEY: Ford’s Health Changes Eye Patient Needs over Political DebateJanuary 21st, 2023
Mother of Three Changes Life After Signing up for Diabetes Research StudyNovember 21st, 2018